Interleukin-12 synthesis is a required step in trehalose dimycolate-induced activation of mouse peritoneal macrophages.

作者: I P Oswald , C M Dozois , J F Petit , G Lemaire

DOI: 10.1128/IAI.65.4.1364-1369.1997

关键词:

摘要: Trehalose dimycolate (TDM), a glycolipid present in the cell wall of Mycobacterium spp., is powerful immunostimulant. TDM primes murine macrophages (Mphi) to produce nitric oxide (NO) and develop antitumoral activity upon activation with low doses lipopolysaccharide (LPS). In this study, we investigated ability induce interleukin 12 (IL-12) role cytokine TDM-induced Mphi. RNA isolated from peritoneal exudate cells (PEC) collected at different times after injection was used determine IL-12 (p35 p40 subunits) gamma interferon (IFN-gamma) mRNA levels by semiquantitative reverse transcriptase-PCR. Constitutive expression IL-12p35 observed PEC untreated as well TDM-injected mice. contrast, IL-12p40 subunit almost undetectable control but dramatically upregulated peaked 8 h subsided baseline 39 postinjection. also able IFN-gamma expression; however, kinetics induction that IL-12p40. Maximal were reached 24 did not return 4 days. addition, pretreatment mice neutralizing monoclonal antibodies directed against (C15.6.7 C15.1.2) blocked TDM-treated We further determined if and/or contributes vivo priming effect on treated anti-IL-12 or anti-IFN-gamma (XMG.1.6) antibodies. TDM-primed Mphi then activated vitro LPS tested for their NO cytostatic toward cocultivated L1210 tumor cells. Priming completely neutralization either demonstrated an absence tumoricidal production TDM-elicited presence LPS. Taken together our results show TDM, defined molecule M. tuberculosis, induces IL-12. Moreover, synthesis mediates mouse through induction.

参考文章(39)
R Appelberg, R A Silva, A G Castro, Endogenously produced IL-12 is required for the induction of protective T cells during Mycobacterium avium infections in mice. Journal of Immunology. ,vol. 155, pp. 2013- 2019 ,(1995)
M A Nalesnik, H Tahara, M T Lotze, P D Robbins, M R Clarke, W J Storkus, L Zitvogel, Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts. Journal of Immunology. ,vol. 155, pp. 1393- 1403 ,(1995)
B. L. Haagmans, M. C. Horzinek, V. E. C. J. Schijns, IL-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in IFN-gamma-receptor-deficient mice. Journal of Immunology. ,vol. 155, pp. 2525- 2532 ,(1995)
Thomas M. Shinnick, Thomas M. Shinnick, Marianne J. Skeen, Mark Miller, Harry Kirk Ziegler, Regulation of murine macrophage IL-12 production. Activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines. Journal of Immunology. ,vol. 156, pp. 1196- 1206 ,(1996)
G Lemaire, M Lepoivre, J P Tenu, J F Petit, Antitumor activity and hydrogen peroxide release by macrophages elicited by trehalose diesters. Journal of Immunology. ,vol. 129, pp. 860- 866 ,(1982)
A P Mountford, R A Wilson, S Anderson, Induction of Th1 cell-mediated protective immunity to Schistosoma mansoni by co-administration of larval antigens and IL-12 as an adjuvant. Journal of Immunology. ,vol. 156, pp. 4739- 4745 ,(1996)
E Y Denkers, S Hieny, R T Gazzinelli, P Caspar, A Sher, M Wysocka, S Hayashi, G Trinchieri, Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. Journal of Immunology. ,vol. 153, pp. 2533- 2543 ,(1994)
Vincenzo Bronte, Nicholas P. Restifo, Steven A. Rosenberg, Bernard Moss, Kari R. Irvine, Ronald S. Chamberlain, Jay B. Rao, Miles W. Carroll, IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression. Journal of Immunology. ,vol. 156, pp. 3357- 3365 ,(1996)
William Gause, A. W. Cheever, T. A. Wynn, I. Eltoum, F. A. Lewis, A. Sher, Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. Journal of Immunology. ,vol. 151, pp. 1430- 1440 ,(1993)
D J Rawlings, D C Kaslow, Adjuvant-dependent immune response to malarial transmission-blocking vaccine candidate antigens. Journal of Experimental Medicine. ,vol. 176, pp. 1483- 1487 ,(1992) , 10.1084/JEM.176.5.1483